Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Zosano Pharma (ZSAN)

1.36   -0.03 (-2.16%) 08-13 16:00
Open: 1.36 Pre. Close: 1.39
High: 1.37 Low: 1.3
Volume: 3,189,094 Market Cap: 93M
Zosano Pharma Corporation, a clinical stage biopharmaceutical company, focuses on providing therapeutics to patients suffering from migraine using its Adhesive Dermally-Applied Microarray technology. Its lead product candidate is Qtrypta (M207), a proprietary formulation of zolmitriptan used for the treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.373 - 1.381 1.381 - 1.387
Low: 1.281 - 1.292 1.292 - 1.299
Close: 1.346 - 1.362 1.362 - 1.374

Technical analysis

as of: 2020-08-13 4:40:00 PM
Overall:       
Stoxline posted a SELL today, upgraded from strong sell. Downward movement continues, but could change at any time.
Target: Six months: 1.92     One year: 2.24
Support: Support1: 1.09    Support2: 0.75
Resistance: Resistance1: 1.64    Resistance2: 1.92
Pivot: 1.18
Moving Average: MA(5): 1.49     MA(20): 1.12
MA(100): 0.86     MA(250): 1.26
MACD: MACD(12,26): 0.16     Signal(9): 0.12
Stochastic oscillator: %K(14,3): 74.70     %D(3): 83.13
RSI: RSI(14): 65.32
52-week: High: 2.80  Low: 0.41  Change(%): -50.9
Average Vol(K): 3-Month: 327959  10-Days: 966197

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
ZSAN has closed below upper band by 33.9%. Bollinger Bands are 301.7% wider than normal. The large width of the bands suggest high volatility as compared to ZSAN's normal range. The bands have been in this wide range for 7 bars. This is a sign that the current trend might continue.

Headline News

Fri, 14 Aug 2020
A Look At The Behavior Of Zosano Pharma Corporation (ZSAN) Stock - Stocks Register

Thu, 13 Aug 2020
Zosano Pharma Corporation (NASDAQ:ZSAN) Up Almost 69.51% in 1 Month, Long Term Looking Good As Well - Marketing Sentinel

Wed, 12 Aug 2020
Is Zosano Pharma Corp (ZSAN) Stock Near the Top of the Biotechnology Industry? - InvestorsObserver

Wed, 12 Aug 2020
Zosano Pharma partners with Eversana Life Science, announces $5M revolving credit facility - Seeking Alpha

Tue, 11 Aug 2020
Zosano Pharma Corporation 8-K Aug. 11, 2020 4:12 PM - Seeking Alpha

Fri, 07 Aug 2020
Zosano Pharma Corporation (ZSAN) is on the roll with an average volume of 2.67M in the recent 3 months - The InvestChronicle

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 54
Shares Float (M) 49
% Held by Insiders 0.23
% Held by Institutions 25.89
Shares Short (K) 5,680
Shares Short P. Month (K) 6,020

Stock Financials

EPS -1.641
EPS Est This Year -0.850
EPS Est Next Year -0.850
Book Value (p.s.) 0.440
Profit Margin
Operating Margin
Return on Assets (ttm) -49.7
Return on Equity (ttm) -219.2
Qtrly Rev. Growth
Gross Profit (p.s.) -0.467
Sales Per Share
EBITDA (p.s.) -0.651
Qtrly Earnings Growth
Operating Cash Flow (M) -36
Levered Free Cash Flow (M) -26

Stock Valuations

PE Ratio -0.83
PEG Ratio
Price to Book value 3.09
Price to Sales
Price to Cash Flow -2.07

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.